Okairos

About:

Okairos AG is a biopharmaceutical company focused on the discovery and development of genetic T-cell vaccines, including hepatitis C virus.

Website: http://www.okairos.com

Top Investors: Versant Ventures, Novartis Venture Fund, EQT Life Sciences, Boehringer Ingelheim Venture Fund, BioMedPartners

Description:

Okairos AG, a bio-pharmaceutical company, focuses on the discovery and development of genetic T-cell vaccines, including hepatitis C virus. The company also provides health and allied services. It has operations in Rome and Naples, Italy. The company is based in Basel, Switzerland. Okairos AG was former subsidiary of Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa.